Dantrolene

Points clés

  • We recommend to consult your poison centre with the use of this antidote.
  • The only known indication for dantrolene is the treatment of malignant hyperthermia (pathology of striated muscle), since it is not a centrally acting drug.
  • Each vial of intravenous dantrolene contains 3 g of mannitol.

© Centre antipoison du Québec, CIUSSS de la Capitale-Nationale, 2017. The information contained in this site may be cited, provided the source is acknowledged. Any use for commercial or advertising purposes is strictly prohibited.

Dernière mise à jour: 01-01-1970